Trials / Terminated
TerminatedNCT00493038
Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis
Prospective, Multicenter, Randomized, Double Blind, Parallel Arm Study to Evaluate the Efficacy and Safety of Moxifloxacin 400 mg OD for 7 Days Versus a Standard Antibiotic Therapy for 10 Days in the Treatment of Acute Bacterial Rhino Sinusitis
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 293 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study organized to collect clinical data to better define the activity of some antimicrobials already marketed in Italy and in the rest of the world for the treatment of acute bacterial rhinosinusitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin (Avelox, BAY12-8039) | Patients will be administered daily a single moxifloxacin 400 mg tablet for 7 days |
| DRUG | Amoxicillin/Clavulanate | Patient will be administered daily Amoxicilline/Clavulanate 1000 mg tablets every 8 hours for 10 days |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2007-06-27
- Last updated
- 2014-11-07
- Results posted
- 2009-04-13
Locations
34 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00493038. Inclusion in this directory is not an endorsement.